Haas Jason bought LGND
August 12, 2026 · Form 4 insider transaction
Haas Jason bought 6,138 shares of Ligand Pharmaceuticals Incorporated at $51.56 per share, a transaction worth $316.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,138
Price
$51.56
Total value
$316.5K
InsiderHaas Jason
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after11,119
OwnershipDirect
10b5-1 planNo
AmendedNo